Breast cancer (BrCa) preferentially spreads to bone and colonizes within the bone marrow to cause bone metastases. To improve the outcome of patients with breast cancer bone metastasis, we need to understand better the mechanisms underlying bone metastasis. Researchers have relied heavily upon in vivo xenografts due to limited availibility of human bone metastasis samples. A significant limitation of these is that they do not have a human bone microenvironment. To address this issue, we have developed a nanoclay based 3D in vitro model of breast cancer bone metastasis using human breast cancer cells mimicking late stage of breast cancer pathogenesis at the metastatic site. This 3D model can provide a microenvironment suitable for cell‐cell, and cell‐matrix interactions while retaining the behavior of BrCa cells with different metastasis potential (i.e., highly metastatic MDA‐MB‐231, and low metastatic MCF‐7) as shown by the production of alkaline phosphatase (ALP) and matrix metalloproteinase‐9 (MMP‐9). The sequential culture of mesenchymal stem cells (MSCs) with MCF‐7 exhibited 3D tumoroids formation and also occurrence of mesenchymal to epithelial transition of cancer metastasis as evidenced by gene expression and immunocytochemistry. The unique and distinct behavior of highly metastatic MDA‐MB‐231 and the low metastatic MCF‐7 was observed at the bone metastasis site. The changes to migratory capabilities and invasiveness in MDA‐MB‐231 in comparison to tumor growth with MCF‐7 was observed. Together, a novel bone‐mimetic 3D in vitro breast cancer model has been developed that could be used to study mechanisms governing the later stage of cancer pathogenesis in bone.
Metastatic prostate cancer spreads preferentially to the bone, causing skeletal complications associated with significant morbidity and a poor prognosis, despite current therapeutic approaches. Hence, it is imperative to understand the complex metastatic cascade to develop therapeutic interventions for treating metastatic prostate cancer. Increasing evidence suggests the synergistic role of biochemical and biophysical cues in cancer progression at metastases. However, the mechanism underlying the crosstalk between interstitial flow-induced mechanical stimuli and prostate cancer progression at the bone microenvironment remains poorly understood. To this end, we have developed a three-dimensional (3D) in vitro dynamic model of prostate cancer bone metastasis using perfusion bioreactor and compared our results with static conditions to delineate the role of flow-induced shear stress on prostate cancer progression at metastases. We observed an increase in human mesenchymal stem cell (hMSCs) proliferation and differentiation rate under the dynamic culture. The hMSCs form cell agglutinates under static culture, whereas the hMSCs exhibited a directional alignment with broad and flattened morphology under dynamic culture. Further, the expression of mesenchymal to epithelial transition biomarkers is increased in bone metastasized prostate cancer models, and large changes are observed in the cellular and tumoroid morphologies under dynamic culture. Evaluation of cell adhesion proteins indicated that the altered cancer cell morphologies resulted from the constant force pulling due to increased E-cadherin and phosphorylated focal adhesion kinase proteins under shear stress. Overall, we report a successful 3D in vitro dynamic model to recapitulate bone metastatic prostate cancer behavior under dynamic conditions.
1 November 2020 in Colloids and Surfaces B: Biointerfaces